Cleared Traditional

K183219 - Trio-CT Triple Lumen Catheter (FDA 510(k) Clearance)

Jun 2019
Decision
206d
Days
Class 2
Risk

K183219 is an FDA 510(k) clearance for the Trio-CT Triple Lumen Catheter. This device is classified as a Catheter, Hemodialysis, Triple Lumen, Non-implanted (Class II - Special Controls, product code NIE).

Submitted by Medical Components, Inc. (dba MedComp) (Harleysville, US). The FDA issued a Cleared decision on June 14, 2019, 206 days after receiving the submission on November 20, 2018.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5540. Short-term (< 30 Days) Central Venous Access For Hemodialysis And Apheresis, With A Third Lumen For Infusion..

Submission Details

510(k) Number K183219 FDA.gov
FDA Decision Cleared Substantially Equivalent - De Novo Granted (SEKD)
Date Received November 20, 2018
Decision Date June 14, 2019
Days to Decision 206 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code NIE — Catheter, Hemodialysis, Triple Lumen, Non-implanted
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.5540
Definition Short-term (< 30 Days) Central Venous Access For Hemodialysis And Apheresis, With A Third Lumen For Infusion.